Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer targets, founded by MPM Capital
45 employees · est. 2021 · Cambridge, United States
Vaccentis
VACCENTIS FOCUSES ON DEVELOPING IMMUNO-ONCOLOGY VACCINES UTILISING ITS AUTOLOGOUS TUMOUR VACCINE TECHNOLOGY PLATFORM
5 employees · est. 2006 · Zurich, Switzerland
Vaccentis is the older company (2021 vs 2006); Crossbow Therapeutics, Inc is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Crossbow Therapeutics, Inc | Vaccentis |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2006 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Zurich, Switzerland |
| Employees | ||
| Employees | 45 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Not tracked yet |
| Total Funding | ||
| Total Funding | $157.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Development of TCR-mimetic antibodies, Cancer antigen targeting, Clinical trials, Therapeutic discovery and development | Not tracked yet |
| Target Customers | ||
| Target Customers | Oncologists, Cancer research institutions, Pharmaceutical companies, Patients with cancer | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Antibody Engineering, Intracellular Cancer Targets, Immunotherapy, T-cell Receptor Mimetic Antibodies, T-Bolt Therapies, Next-Generation Immunotherapy, Selective Cancer Targeting, Cancer Protein Targeting, Cancer Treatment Innovation, Therapeutic Potential, Cancer Patient Care, Precision Medicine, MPM Capital | Immunotherapy, Cancer Vaccines, Oncology, Tumor Vaccine Technology, Autoimmune Oncology, Renal Cell Carcinoma, Metastatic Cancer Treatment, Clinical Research, Patient-Specific Medicines, Evidence-Based Medicine, Medical Product Development, Natural Medicine, Biopharmaceuticals |
| Website | ||
| Website | crossbowtx.com | vaccentis.com |
About Crossbow Therapeutics, Inc
Crossbow Therapeutics, Inc, founded in 2021, is a pioneering biotechnology company headquartered in the United States. Their mission is to revolutionize cancer treatment through the development of TCR-mimetic antibodies, leveraging their proprietary T-Bolt™ therapies to precisely target cancer cells...
About Vaccentis
Vaccentis is a health care startup with a focus on developing immuno-oncology vaccines utilizing its autologous tumor vaccine technology platform. The company was founded in 2006 and is currently in the late stage development of an autologous tumor vaccine for Renal Cell Carcinoma. Their medical div...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Crossbow Therapeutics, Inc and Vaccentis — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Crossbow Therapeutics,... and Vaccentis — by email.
Frequently Asked Questions
Compare Crossbow Therapeutics, Inc with someone else
Start typing a company name or domain.